CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting.
| Image |  |
|---|---|
| Description | scientific article published on 28 December 2017 |
| Author/s |
author: Niklas Landberg Satu Mustjoki Henrik Lilljebjörn Marcus Järås |
| Publication date | December 28, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |